1 |
WANG R, LI R, YANG H, et al. Flavokawain C inhibits proliferation and migration of liver cancer cells through FAK/PI3K/AKT signaling pathway[J]. J Cancer Res Clin Oncol, 2024,150(3):117-133. doi:10.1007/s00432-024-05639-z
doi: 10.1007/s00432-024-05639-z
|
2 |
PARK H, LEE S, LEE J, et al. Exploring the JAK/STAT signaling pathway in hepatocellular carcinoma: Unraveling signaling complexity and therapeutic implications[J]. Int J Mol Sci, 2023,24(18):13764-13786. doi:10.3390/ijms241813764
doi: 10.3390/ijms241813764
|
3 |
GUO F, YANG X, HU C, et al. Network pharmacology combined with machine learning to reveal the action mechanism of licochalcone intervention in liver cancer[J]. Int J Mol Sci,2023,24(21):15935-15960. doi:10.3390/ijms242115935
doi: 10.3390/ijms242115935
|
4 |
BAO X, HU J, ZHAO Y, et al. Advances on the anti-tumor mechanisms of the carotenoid Crocin[J]. PeerJ, 2023,11:e15535. doi:10.7717/peerj.15535
doi: 10.7717/peerj.15535
|
5 |
HU X, WANG J, SHANG P, et al. Sauchinone inhibits breast cancer cell proliferation through regulating microRNA-148a-3p/HER-2 axis[J]. Thorac Cancer, 2023,14(13):1135-1144. doi:10.1111/1759-7714.14834
doi: 10.1111/1759-7714.14834
|
6 |
KIM Y W, JANG E J, KIM C H, et al. Sauchinone exerts anticancer effects by targeting AMPK signaling in hepatocellular carcinoma cells[J]. Chem Biol Interact, 2017,261:108-117. doi:10.1016/j.cbi.2016.11.016
doi: 10.1016/j.cbi.2016.11.016
|
7 |
GAO W, LU Y X, WANG F, et al. miRNA-217 inhibits proliferation of hepatocellular carcinoma cells by regulating KLF5[J]. Eur Rev Med Pharmacol Sci, 2019,23(18):7874-7883.
|
8 |
WANG H, HOU W, PERERA A, et al. Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1/STAT3 and AKT signaling[J]. Cell Rep,2021,34(8):108765-108805. doi:10.1016/j.celrep.2021.108765
doi: 10.1016/j.celrep.2021.108765
|
9 |
PAPACONSTANTINOU D, TSILIMIGRAS D I, PAWLIK T M. Recurrent hepatocellular carcinoma: Patterns, detection, staging and treatment[J]. J Hepatocell Carcinoma, 2022,9:947-957. doi:10.2147/jhc.s342266
doi: 10.2147/jhc.s342266
|
10 |
沈未,鲁迪,徐骁. 肝癌肝移植适应证的科学演进[J]. 器官移植,2025,16(2):202-207.
|
11 |
CHEN C, WANG Z, DING Y, et al. Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma[J]. Front Immunol, 2023,14:1133308. doi:10.3389/fimmu.2023.1133308
doi: 10.3389/fimmu.2023.1133308
|
12 |
ZHOU W, YANG F. Circular RNA circRNA-0039459 promotes the migration, invasion, and proliferation of liver cancer cells through the adsorption of miR-432[J]. Bioengineered, 2022,13(5):11810-11821. doi:10.1080/21655979.2022.2073129
doi: 10.1080/21655979.2022.2073129
|
13 |
KIM N H, SUNG N J, SHIN S, et al. Sauchinone inhibits the proliferation, migration and invasion of breast cancer cells by suppressing Akt-CREB-MMP13 signaling pathway[J]. Biosci Rep, 2021,41(10):BSR20211067. doi:10.1042/bsr20211067
doi: 10.1042/bsr20211067
|
14 |
LU Y, YU M, YE J, et al. Sauchinone inhibits the proliferation and immune invasion capacity of colorectal cancer cells through the suppression of PD-L1 and MMP2/MM9[J]. Anticancer Agents Med Chem,2023,23(12):1406-1414. doi:10.2174/1871520623666230320125406
doi: 10.2174/1871520623666230320125406
|
15 |
LI S Q, FENG J, YANG M, et al. Sauchinone: A prospective therapeutic agent-mediated EIF4EBP1 down-regulation suppresses proliferation, invasion and migration of lung adenocarcinoma cells[J]. J Nat Med, 2020,74(4):777-787. doi:10.1007/s11418-020-01435-4
doi: 10.1007/s11418-020-01435-4
|
16 |
YAO S J, MA H S, LIU G M, et al. Increased IL-1α expression is correlated with bladder cancer malignant progression[J]. Arch Med Sci, 2020,19(1):160-170.
|
17 |
TRIPATHI A K, DESAI P P, TYAGI A, et al. Short peptides based on the conserved regions of MIEN1 protein exhibit anticancer activity by targeting the MIEN1 signaling pathway[J]. J Biol Chem, 2024,300(3):105680-105692. doi:10.1016/j.jbc.2024.105680
doi: 10.1016/j.jbc.2024.105680
|
18 |
SUN J, HU J R, LIU C F, et al. ANKRD49 promotes the metastasis of NSCLC via activating JNK-ATF2/c-Jun-MMP-2/9 axis[J]. BMC Cancer, 2023,23(1):1108. doi:10.1186/s12885-023-11612-9
doi: 10.1186/s12885-023-11612-9
|
19 |
边红艳,张舒,孟珊珊,等. 石榴皮多酚调控miR-138-5p/HIF-1α通路对结肠癌细胞恶性生物学行为的影响[J]. 实用医学杂志,2025,41(5):676-682.
|
20 |
FORTIN B M, PFEIFFER S M, INSUA-RODRÍGUEZ J, et al. Circadian control of tumor immunosuppression affects efficacy of immune checkpoint blockade[J]. Nat Immunol, 2024,25(7):1257-1269. doi:10.1038/s41590-024-01859-0
doi: 10.1038/s41590-024-01859-0
|
21 |
PAN Y, SHU G, FU L, et al. EHBP1L1 drives immune evasion in renal cell carcinoma through binding and stabilizing JAK1[J]. Adv Sci (Weinh),2023,10(11):e2206792. doi:10.1002/advs.202206792
doi: 10.1002/advs.202206792
|
22 |
王芳,胡洁琼,冯彦虎,等. 乌司他丁调节CCL2-CCR2信号轴对胃癌细胞上皮-间质转化和免疫逃逸的影响分析[J]. 中国免疫学杂志,2024,40(2):305-311.
|
23 |
HAO L, LI S, DENG J, et al. The current status and future of PD-L1 in liver cancer[J]. Front Immunol, 2023,14:1323581. doi:10.3389/fimmu.2023.1323581
doi: 10.3389/fimmu.2023.1323581
|
24 |
周智华,常静雯,严元元,等. 参芪扶正注射液增强免疫检查点抑制剂anti-PD-L1抗肿瘤作用及机制研究[J]. 中国临床药理学与治疗学,2024,29 (7):792-799.
|
25 |
ZHAO P, SUN J, HUANG X, et al. Targeting the KLF5-EphA2 axis can restrain cancer stemness and overcome chemoresistance in basal-like breast cancer[J]. Int J Biol Sci, 2023,19(6):1861-1874. doi:10.7150/ijbs.82567
doi: 10.7150/ijbs.82567
|
26 |
WANG Y, YU B, QU M, et al. Britannin inhibits cell proliferation, migration and glycolysis by downregulating KLF5 in lung cancer[J]. Exp Ther Med, 2024,27(3):109-117. doi:10.3892/etm.2024.12397
doi: 10.3892/etm.2024.12397
|
27 |
XIANG Y, HUANG Y, SUN H, et al. Deregulation of miR-520d-3p promotes hepatocellular carcinoma development via lncRNA MIAT regulation and EPHA2 signaling activation[J]. Biomed Pharmacother, 2019,109:1630-1639. doi:10.1016/j.biopha.2018.11.014
doi: 10.1016/j.biopha.2018.11.014
|